Is the door open to further investigation with antiangiogenesis in SCLC?

by Tiseo, Marcello, Boni, Luca, Ardizzoni, Andrea
Published in J Thorac Dis (2018)

It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset

by Ardizzoni, Andrea, Wheeler, Robert T., Pericolini, Eva
Published in Front Microbiol (2021)

Systemic adjuvant therapies in renal cell carcinoma

by Buti, Sebastiano, Bersanelli, Melissa, Donini, Maddalena, Ardizzoni, Andrea
Published in Oncol Rev (2012)

Chemotherapy treatment in malignant pleural mesothelioma: a difficult history

by Cinausero, Marika, Rihawi, Karim, Sperandi, Francesca, Melotti, Barbara, Ardizzoni, Andrea
Published in J Thorac Dis (2018)

Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care

by Massari, Francesco, Mollica, Veronica, Salvagni, Stefania, Tognetto, Michele, Ardizzoni, Andrea
Published in Future Oncol (2020)

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment

by Raschi, Emanuel, Fusaroli, Michele, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio
Published in Breast Cancer Res Treat (2020)

Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System

by Raschi, Emanuel, Fusaroli, Michele, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio
Published in Cancers (Basel) (2021)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporti...

by Gatti, Milo, Raschi, Emanuel, Moretti, Ugo, Ardizzoni, Andrea, Poluzzi, Elisabetta, Diemberger, Igor
Published in Vaccines (Basel) (2021)

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

by Raschi, Emanuel, Gatti, Milo, Gelsomino, Francesco, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio
Published in Target Oncol (2020)

Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines

by de Cupis, Alessandra, Ciomei, Marina, Pirani, Paolo, Ferrera, Alessandra, Ardizzoni, Andrea, Enrico Favoni, Roberto
Published 1997

Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

by Rihawi, Karim, Gelsomino, Francesco, Sperandi, Francesca, Melotti, Barbara, Fiorentino, Michelangelo, Casolari, Laura, Ardizzoni, Andrea
Published in Ther Adv Respir Dis (2017)

Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer

by Parisi, Claudia, Lamberti, Giuseppe, Zompatori, Maurizio, Gelsomino, Francesco, Salvagni, Stefania, Sperandi, Francesca, Ardizzoni, Andrea
Published in J Immunother Cancer (2020)

The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia

by Gatti, Milo, Raschi, Emanuel, Poluzzi, Elisabetta, Martignani, Cristian, Salvagni, Stefania, Ardizzoni, Andrea, Diemberger, Igor
Published in Curr Heart Fail Rep (2020)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers

by Giunchi, Francesca, Massari, Francesco, Altimari, Annalisa, Gruppioni, Elisa, Nobili, Elisabetta, Fiorentino, Michelangelo, Ardizzoni, Andrea
Published in Diagnostics (Basel) (2020)

Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System

by Raschi, Emanuel, Antonazzo, Ippazio Cosimo, La Placa, Michelangelo, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio
Published in Oncologist (2019)

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

by Gridelli, Cesare, Ardizzoni, Andrea, Barberis, Massimo, Cappuzzo, Federico, Casaluce, Francesca, Danesi, Romano, Troncone, Giancarlo, De Marinis, Filippo
Published in Transl Lung Cancer Res (2017)

In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity

by Ardizzoni, Andrea, Pericolini, Eva, Paulone, Simona, Orsi, Carlotta Francesca, Castagnoli, Anna, Oliva, Ilaria, Strozzi, Elena, Blasi, Elisabetta
Published in PLoS One (2018)

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

by Lamberti, Giuseppe, Sisi, Monia, Andrini, Elisa, Palladini, Arianna, Giunchi, Francesca, Lollini, Pier-Luigi, Ardizzoni, Andrea, Gelsomino, Francesco
Published in Cancers (Basel) (2020)

Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis

by Filippini, Daria Maria, Gatti, Milo, Di Martino, Vito, Cavalieri, Stefano, Fusaroli, Michele, Ardizzoni, Andrea, Raschi, Emanuel, Licitra, Lisa
Published in Int J Cancer (2021)

In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid

by Cermelli, Claudio, Cuoghi, Alessandro, Scuri, Monica, Bettua, Clotilde, Neglia, Rachele G, Ardizzoni, Andrea, Blasi, Elisabetta, Iannitti, Tommaso, Palmieri, Beniamino
Published 2011